Cargando…
Tamoxifen reduces plasma homocysteine levels in healthy women.
Treatment with tamoxifen is associated with reduced incidence of myocardial infarction. As plasma homocysteine is an independent risk factor for cardiovascular disease, we studied the effects of tamoxifen on plasma homocysteine in 66 healthy women participating in the Italian prevention trial of bre...
Autores principales: | Cattaneo, M., Baglietto, L., Zighetti, M. L., Bettega, D., Robertson, C., Costa, A., Mannucci, P. M., Decensi, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150392/ https://www.ncbi.nlm.nih.gov/pubmed/9649143 |
Ejemplares similares
-
Air Pollution, Smoking, and Plasma Homocysteine
por: Baccarelli, Andrea, et al.
Publicado: (2007) -
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.
por: Decensi, A., et al.
Publicado: (1998) -
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
por: James, Philip T., et al.
Publicado: (2019) -
Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer
por: Torrisi, R, et al.
Publicado: (2001) -
Daily rhythms in plasma levels of homocysteine
por: Lavie, Lena, et al.
Publicado: (2004)